Focused on acquiring, developing and commercializing innovative anti-cancer agents in the US, Europe and additional international markets
- Year invested 2009
- Investment Stage Early
- Sectors
- Investment Status Current
- Website clovisoncology.com
- Company Status IPO/Public (Nasdaq: CLVS)